Alexis Howerton is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for congenital adrenal hyperplasia (CAH). With a total of 7 patents to her name, Howerton's work is paving the way for advancements in medical therapies.

Latest Patents

Among her latest patents, Howerton has developed novel pharmaceutical compositions that include -(4-Chloro-2-(morpholin-4-yl)thiazol-5-yl)-7-(1-ethylpropyl)-2,5-dimethylpyrazolo(1,5-a)pyrimidine. These compositions are designed for the treatment of congenital adrenal hyperplasia (CAH), showcasing her commitment to addressing critical health issues.

Career Highlights

Howerton is currently associated with Spruce Biosciences, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her expertise and dedication have positioned her as a key player in her field.

Collaborations

Throughout her career, Howerton has collaborated with notable professionals, including Hal Gerber and Michael Guanran Huang. These partnerships have further enhanced her research and development efforts.

Conclusion

Alexis Howerton's innovative work and dedication to improving medical treatments exemplify the impact of inventors in the pharmaceutical industry. Her contributions are vital for advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.